Literature DB >> 1744159

Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell line.

G Chen1, K J Hutter, J Bullerdiek, W J Zeller.   

Abstract

In a rat ovarian tumour cell line a 33-fold resistance to cisplatin (O-342/DDP) was developed in vitro by continuous exposure of the parental cell line (O-342) to stepwise increase cisplatin concentration in the culture medium. Both cell lines had a similar growth rate in vitro. Development of resistance was accompanied by a change of the karyotype from heteroploidy in chemosensitive O-342 cells to near diploidy in resistant O-342/DDP cells as shown by chromosome number distribution. This finding was confirmed by measuring cellular DNA content using flow-cytometry analysis. Flow karyotyping showed significant differences in chromosomal DNA contents between both cell lines. Our results suggest that the parent line O-342 consists of at least two subpopulations, a cisplatin-sensitive and a cisplatin-resistant one, corresponding to hyperploidy and near diploidy, respectively. Continuous cisplatin exposure of O-342 cells selectively killed the sensitive fraction, resulting in the karyotypic change observed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744159     DOI: 10.1007/bf01613285

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  12 in total

1.  In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.

Authors:  G Chen; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Chromosomes and cancer.

Authors:  A Levan; G Levan; F Mitelman
Journal:  Hereditas       Date:  1977       Impact factor: 3.271

3.  Detection and separation of the submetacentric marker chromosome of the WALKER (W-256) carcinoma using flow cytometry and sorting.

Authors:  K J Hutter; M Stoehr
Journal:  Histochemistry       Date:  1985

4.  Genetic instability in the development of drug resistance.

Authors:  J H Goldie; A J Coldman
Journal:  Semin Oncol       Date:  1985-09       Impact factor: 4.929

5.  A reliable preparation of mon-dispersed chromosome suspensions for flow cytometry.

Authors:  M Stoehr; K J Hutter; M Frank; K Goerttler
Journal:  Histochemistry       Date:  1982

Review 6.  Resistance to cisplatin and analogues: mechanisms and potential clinical implications.

Authors:  A de Graeff; R J Slebos; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas.

Authors:  M Jäckel; P Köpf-Maier
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Tumor heterogeneity and drug resistance.

Authors:  D L Dexter; J T Leith
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

9.  Cytogenetic effects of cis-platinum(II)diamminedichloride on human lymphocyte cultures.

Authors:  J Meyne; L H Lockhart
Journal:  Mutat Res       Date:  1978-09       Impact factor: 2.433

Review 10.  Chromosome error propagation and cancer.

Authors:  R Holliday
Journal:  Trends Genet       Date:  1989-02       Impact factor: 11.639

View more
  4 in total

1.  Cell cycle effects of thaliblastine.

Authors:  F Seifert; D K Todorov; K J Hutter; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Inhibition of O6-alkylguanine-DNA alkyltransferase in animal and human ovarian tumor cell lines by O6-benzylguanine and sensitization to BCNU.

Authors:  A Magull-Seltenreich; W J Zeller
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo.

Authors:  G Chen; W J Zeller
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells.

Authors:  G Chen; K J Hutter; W J Zeller
Journal:  Cell Biol Toxicol       Date:  1995-10       Impact factor: 6.691

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.